Great run Clovis had the last days. However i prefer not to buy into runs and wait till my requirements are met.
I marked 3 possible places where i would buy if the following would happen:
- Price gets above the level
- Open and close of a monthly candle above the level, then buy
- Targets are based on the next resistance level
- Stop- Loss: None
Good...
Based on my research, I think that the $3 strike price expiring July 15, with the price of $0.21 or lower is what I would pick right now.
As you know, the OTM options can be profitable even if they don`t reach the strike price.
If the stock moves closer to the strike price after you enter the trade, or if there is a rapid increase in Implied Volatility, you can...
Another bullish looking pick in the same industry. We love impulses, especially we catch them before tehy make themselves apparent.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest,...
CLVS is now back at its November 2020 low. The interesting part of this trend is that it also managed to test, hold, and bounce off of an almost identical level (strong support?). As of Friday afternoon shares retested an interim area of higher traffic that was support earlier in August and late July but now appears to have become a resistance level over the last...
Took the chart back out to March of last year to do a little fib retracement. Wouldn't you know, CLVS has been channel bound for a minute between the 618 and 786 fib lines with pretty clear support and resistance levels at each. Since it retraced back to the 786 again and is holding (for now), volume is likely going to be the "friend" or "foe" depending on how...
CLVS Clovis Oncology is sitting at a strong support area ready for a bounce.
My Price target is the 10usd resistance level
On 5/5/2021 HC Wainwright brokerage Lowered the Price Target for CLVS Clovis Oncology to Buy Rating from $13.00 to$12.00
CLVS has been beat up for a loooong time.
On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy.
Completely a momentum based trade with a tight stop loss.
PS Never ever take any of...
CLOVIS maker of FDA approved Rubraca® which is a treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer whose cancer has come back and who are in response (complete or partial response) to a platinum-based chemotherapy. www.rubraca.com
Sitting at a pretty interesting area right now, sure it will get some more movement soon as we are...
We have a triple rejection of the sub 8.60 price range on the weekly candles, setup doesn't get much better than that. Consolidation has taken longer than expected but what else is new haha.
I think we will see a sharp move this month. From reading the chart alone I am wagering it's going to be a bullish move... even though the fundamentals of the company are up for debate.
Bullish view on Clovis Oncology as it breaks $30 price resistance.
CLVS jumped 13% last Wednesday as sales of its Rubraca drug used to treat ovarian cancer patients went up 33% compared to previous quarter.
A few thoughts on CLVS. May not pan out, but this is a bullish scenario.
Reasons the bull scenario could play out from a technical standpoint:
1. Move up to $99 was a clear 5 waves. It looks to have recently completed the ABC correction into a perfect golden pocket 61.8 to 65% retracement.
2. Wave C was an ending diagonal. CLVS has broken out of the diagonal...
